Efficacy and safety of canakinumab in patients with adult-onset Still’s disease: Results from an open-label phase III study in Japan

Modern Rheumatology · Published 2026-03-23 · DOI 10.1093/mr/roag026

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1093/mr/roag026

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Clinical performance of three anti-dsDNA antibody immunoassays in systemic lupus erythematosus · Modern Rheumatology · 2026 · Same journal
• Autoantibodies against adenosine deaminase acting on RNA1 in patients with systemic lupus erythematosus: Its relationship to clinical features and other autoantibodies · Modern Rheumatology · 2026 · Same journal
• Treatment outcomes of periprosthetic fracture following unlinked total elbow arthroplasty: A case series study · Modern Rheumatology · 2026 · Same journal
• Disentangling temporal factors in organ damage accrual in systemic lupus erythematosus: Onset-age, onset-era, and ageing in the Japanese LUNA registry · Modern Rheumatology · 2026 · Same journal
• Inebilizumab treatment in Japanese patients with IgG4-related disease: A subgroup analysis of a randomized, double-blind, placebo-controlled, phase 3 trial (MITIGATE) · Modern Rheumatology · 2026 · Same journal
• Prevalence of and factors associated with radiographic sacroiliitis in Japanese patients with inflammatory bowel disease: A computed tomography–based study · Modern Rheumatology · 2026 · Same journal
• Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry · Modern Rheumatology · 2026 · Same journal
• Impact of anti-drug antibodies and neutralising antibodies on safety and efficacy of ozoralizumab in rheumatoid arthritis · Modern Rheumatology · 2026 · Same journal
• Assessment of residual symptoms using the Okomarigoto Sheet can complement evaluation of the patient acceptable symptom state in patients with rheumatoid arthritis · Modern Rheumatology · 2026 · Same journal
• A proposal for the implementation of telemedicine in Japan for rheumatoid arthritis, juvenile idiopathic arthritis, and systemic lupus erythematosus: Review article · Modern Rheumatology · 2026 · Same journal